Sang Froid Labs (India) reports standalone net loss of Rs 0.10 crore in the September 2018 quarter
18 - Nov - 2018 12:00 | 2389 days ago
Net loss of Sang Froid Labs (India) reported to Rs 0.10 crore in the quarter ended September 2018 as against net profit of Rs 0.02 crore during the previous quarter ended September 2017. There were no Sales reported in the quarter ended September 2018 as against Rs 0.10 crore during the previous quarter ended September 2017.
Sang Froid Labs (India) reports standalone net loss of Rs 0.10 crore in the September 2018 quarter
18 - Nov - 2018 12:00 | 2389 days ago
Net loss of Sang Froid Labs (India) reported to Rs 0.10 crore in the quarter ended September 2018 as against net profit of Rs 0.02 crore during the previous quarter ended September 2017. There were no Sales reported in the quarter ended September 2018 as against Rs 0.10 crore during the previous quarter ended September 2017.
Sang Froid Labs (India) receives license for wholesale drugs
17 - Oct - 2018 12:00 | 2421 days ago
Sang Froid Labs (India) has received license to sell, stock or exhibit or offer for sale, or distribute by Wholesale drugs specified in Schedules C and C(1) [excluding those specified in schedule x] as per the Drugs and Cosmetics Rules, 1945 in form 21B and the Company has received license to sell, stock or exhibit or offer for sale, or distribute by Wholesale drugs specified Other Than Those Specified in Schedules C and C(1) and in schedule x as per the Drugs and Cosmetics Rules, 1945 in form 20B at the premises situated at F-118, Signature Complex ,Sur No.340, TP No.38, FP no. 223,224 Opp Suvarna Bung, 100 Ft Hebatpur Road, Thaltej , Ahmedabad. Further the license shall be in force from 12 October 2018 to 11 October 2023.
Sang Froid Labs (India) reports standalone net loss of Rs 0.10 crore in the September 2018 quarter
18 - Nov - 2018 12:00 | 2389 days ago
Net loss of Sang Froid Labs (India) reported to Rs 0.10 crore in the quarter ended September 2018 as against net profit of Rs 0.02 crore during the previous quarter ended September 2017. There were no Sales reported in the quarter ended September 2018 as against Rs 0.10 crore during the previous quarter ended September 2017.
Sang Froid Labs (India) receives license for wholesale drugs
17 - Oct - 2018 12:00 | 2421 days ago
Sang Froid Labs (India) has received license to sell, stock or exhibit or offer for sale, or distribute by Wholesale drugs specified in Schedules C and C(1) [excluding those specified in schedule x] as per the Drugs and Cosmetics Rules, 1945 in form 21B and the Company has received license to sell, stock or exhibit or offer for sale, or distribute by Wholesale drugs specified Other Than Those Specified in Schedules C and C(1) and in schedule x as per the Drugs and Cosmetics Rules, 1945 in form 20B at the premises situated at F-118, Signature Complex ,Sur No.340, TP No.38, FP no. 223,224 Opp Suvarna Bung, 100 Ft Hebatpur Road, Thaltej , Ahmedabad. Further the license shall be in force from 12 October 2018 to 11 October 2023.
Sang Froid Labs (India) reports standalone net loss of Rs 0.10 crore in the September 2018 quarter
18 - Nov - 2018 12:00 | 2389 days ago
Net loss of Sang Froid Labs (India) reported to Rs 0.10 crore in the quarter ended September 2018 as against net profit of Rs 0.02 crore during the previous quarter ended September 2017. There were no Sales reported in the quarter ended September 2018 as against Rs 0.10 crore during the previous quarter ended September 2017.
Sang Froid Labs (India) reports standalone net loss of Rs 0.10 crore in the September 2018 quarter
18 - Nov - 2018 12:00 | 2389 days ago
Net loss of Sang Froid Labs (India) reported to Rs 0.10 crore in the quarter ended September 2018 as against net profit of Rs 0.02 crore during the previous quarter ended September 2017. There were no Sales reported in the quarter ended September 2018 as against Rs 0.10 crore during the previous quarter ended September 2017.
Sang Froid Labs (India) receives license for wholesale drugs
17 - Oct - 2018 12:00 | 2421 days ago
Sang Froid Labs (India) has received license to sell, stock or exhibit or offer for sale, or distribute by Wholesale drugs specified in Schedules C and C(1) [excluding those specified in schedule x] as per the Drugs and Cosmetics Rules, 1945 in form 21B and the Company has received license to sell, stock or exhibit or offer for sale, or distribute by Wholesale drugs specified Other Than Those Specified in Schedules C and C(1) and in schedule x as per the Drugs and Cosmetics Rules, 1945 in form 20B at the premises situated at F-118, Signature Complex ,Sur No.340, TP No.38, FP no. 223,224 Opp Suvarna Bung, 100 Ft Hebatpur Road, Thaltej , Ahmedabad. Further the license shall be in force from 12 October 2018 to 11 October 2023.
